CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Open-market sale SVP, General Counsel, Sec. sold 1,484 shares at $9.54 ($14,160)
- 4/A Open-market sale SVP, General Counsel, Sec. sold 1,483 shares at $9.09 ($13,478)
- 4/A Open-market sale SVP, General Counsel, Sec. sold 1,715 shares at $11.46 ($19,655)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale Director sold 996 shares at $9.09 ($9,052)
- 4/A Open-market sale Director sold 995 shares at $11.46 ($11,403)
- 4/A Open-market sale Director sold 11,933 shares at an average $11.23 ($134,035)
- 4 Exercise or conversion CEO and President acquired 50,000 shares (option exercise)
- 4 Open-market buy Director bought 420,000 shares at $8.25 ($3,465,000)
- 4 Open-market sale Director sold 996 shares at $9.09 ($9,052)
- 4 Open-market sale SVP, General Counsel, Sec. sold 1,483 shares at $9.09 ($13,478)
- 4 Exercise or conversion CEO and President acquired 100,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 16 of 19 · 378 filings